Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.
about
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventionsDiabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future researchDiabetic Cardiomyopathy; Summary of 41 YearsHow exercise may amend metabolic disturbances in diabetic cardiomyopathyDiabetic cardiomyopathy: bench to bedsideExtracts of Magnolia Species-Induced Prevention of Diabetic Complications: A Brief ReviewThe Flexibility of Ectopic LipidsNonalcoholic fatty liver disease - A multisystem disease?The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart FailureMitochondrial dynamics in diabetic cardiomyopathyNoninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of CardiologyAlterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease.Diabetic cardiomyopathy: pathophysiology and clinical featuresImaging myocardial metabolic remodeling.Bayesian parameter estimation for characterizing the cyclic variation of echocardiographic backscatter to assess the hearts of asymptomatic type 2 diabetes mellitus subjects.Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis.Quantitative analysis of the magnitude and time delay of cyclic variation of myocardial backscatter from asymptomatic type 2 diabetes mellitus subjects.Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease.Cardiac proton spectroscopy using large coil arrays.(1)H-MR spectroscopy for analysis of cardiac lipid and creatine metabolism.Quantification of Intramyocardial Metabolites by Proton Magnetic Resonance Spectroscopy.Myocardial triglyceride content at 3 T cardiovascular magnetic resonance and left ventricular systolic function: a cross-sectional study in patients hospitalized with acute heart failure.Myocardial fat quantification in humans: Evaluation by two-point water-fat imaging and localized proton spectroscopy.Myocardial Fat Imaging.Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart.Association of Non-alcoholic Fatty Liver Disease with Conduction Defects on Electrocardiogram.Insulin secretion and computed tomography values of the pancreas in the early stage of the development of diabetesMetabolic Remodeling in Diabetic Cardiomyopathy.Lipotoxicity in the heart.Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities.Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetesNon-Alcoholic Fatty Liver Disease Association with Cardiac ArrhythmiasDiabetic cardiomyopathy: where we are and where we are going.Impact of glycemic control on aortic stiffness, left ventricular mass and diastolic longitudinal function in type 2 diabetes mellitusDiastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosisAssociation of glucose metabolism with diastolic function along the diabetic continuumSphingolipids in obesity, type 2 diabetes, and metabolic disease.Deficiency of a lipid droplet protein, perilipin 5, suppresses myocardial lipid accumulation, thereby preventing type 1 diabetes-induced heart malfunctionMolecular determinants of the cardiometabolic phenotype.Myocardial steatosis and its association with obesity and regional ventricular dysfunction: evaluated by magnetic resonance tagging and 1H spectroscopy in healthy African Americans.
P2860
Q21285128-238028E8-D309-4ED8-8758-7A126715CE59Q26782844-22219136-2A0F-4BFF-9854-EC408B78BFF1Q26799318-4121B9E4-33AE-4B42-8063-FDC85FEFC168Q26863272-8ED3624A-A17C-411B-BC99-24271E5C8C24Q26997062-05DAEF1C-C661-43D6-B88C-8A4A583938B5Q28073215-79CD8313-8416-4E64-A802-C1146452D60DQ28076063-4836ACBA-5705-41A2-9642-E0253A2485D3Q28079077-0CF7F4E9-402A-4B2C-986C-5797CD80E4D1Q28082343-3153E1A6-54E4-42F5-ABDD-F2C463B052A9Q28395223-CD4E803D-C2C6-4B25-9A69-414625747458Q30277401-2977CA3C-5D1F-4587-B2A2-EA783C990243Q30437623-242CBD4A-99DD-46CC-987D-8D1068318573Q30457504-34524DAF-6DB9-46F7-856D-D8F69CCB85A4Q30464469-07B4A69A-EC29-4A23-AED5-602137702367Q30468216-9D9ACA8E-EA44-4E4C-9B60-D6B1B8DAA80CQ30476724-58338EAE-898B-4368-9363-6D5E8F5AADD4Q30479827-77F1DB0D-46F5-4F85-92F0-8A0222B86BABQ30483398-A0311A01-CA05-41C4-887B-AF9A77E3DCE0Q30559856-CC98BEB2-866D-41CD-955F-61E436857E76Q30560950-CECE20BC-1090-46A0-A3A1-14E06F2D78AEQ31032000-C3B3D0D9-8600-48AF-BB2A-B6BCDA71D490Q31043315-50BCF59C-6362-426A-84BD-462FE9751766Q33550436-5325025C-D49F-43F9-A47A-E35C54969448Q33558597-16DDAFAC-8C86-428F-96D2-4087EFF75377Q33566045-226F1B1E-E438-4B4E-82CD-B6871F4729F1Q33591227-EA31A094-5A56-4E6B-9826-FF752B193E30Q33603352-50B6978C-3256-4B54-98B7-7BD753958146Q33623469-8755C41D-2AD9-4D1A-8CFA-A88D0E22BD66Q33665107-23B1DFBE-35C1-472E-AFBE-5190B6B48FC1Q33668501-7DA3DAB9-45A6-4A20-83A4-8B8A916D0863Q33671476-17FBCF0B-CFC8-437F-8B84-9696D4AF8ED2Q33675914-9EFFB6D3-9C2D-48B8-B7BD-059FBE437049Q33690717-D9289140-69AE-4E74-9CDC-7FD0EAAD1B04Q33808313-10E13375-74D8-49E5-A7EA-4B2E4FE0DDA6Q33814148-11B3AC1F-64CA-4286-A211-4D53A7D7E4E6Q33880289-2F97AD9C-2346-4674-B026-B56C003475EEQ33880588-55125AB9-7D79-4A21-B1AC-EDC1A823FAF6Q33899819-651C8B02-C196-4810-B4A3-C0D67713A046Q33921392-85E85BBF-CC0F-4FEC-AF51-903F87D32B43Q33922106-933E14FF-AF0E-4687-97B1-376F3848DE27
P2860
Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Myocardial steatosis is an ind ...... n in type 2 diabetes mellitus.
@ast
Myocardial steatosis is an ind ...... n in type 2 diabetes mellitus.
@en
type
label
Myocardial steatosis is an ind ...... n in type 2 diabetes mellitus.
@ast
Myocardial steatosis is an ind ...... n in type 2 diabetes mellitus.
@en
prefLabel
Myocardial steatosis is an ind ...... n in type 2 diabetes mellitus.
@ast
Myocardial steatosis is an ind ...... n in type 2 diabetes mellitus.
@en
P2093
P1476
Myocardial steatosis is an ind ...... n in type 2 diabetes mellitus.
@en
P2093
Albert de Roos
Hildo J Lamb
Johannes A Romijn
Johannes W A Smit
Luuk J Rijzewijk
Michaela Diamant
Rutger W van der Meer
Sebastiaan Hammer
P304
P356
10.1016/J.JACC.2008.07.062
P407
P577
2008-11-01T00:00:00Z